AH Lisanti Capital Growth »

Palvella Therapeutics Inc Ne shares owned by AH Lisanti Capital Growth

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by AH Lisanti Capital Growth from 13F filings

Historical chart of AH Lisanti Capital Growth investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by AH Lisanti Capital Growth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by AH Lisanti Capital Growth

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.3M 42k 104.67

More positions owned by AH Lisanti Capital Growth

Jfrog Ord Shs (FROG)
Carpenter Technology Corporation (CRS)
Ligand Pharmaceuticals Com New (LGND)
Five Below (FIVE)
Sitime Corp (SITM)
Huron Consulting (HURN)
Alphatec Hldgs Com New (ATEC)
Knight-swift Transn Hldgs In Cl A (KNX)
Boot Barn Hldgs (BOOT)
Dycom Industries (DY)
Transmedics Group (TMDX)
Mercury Computer Systems (MRCY)
John Bean Technologies Corporation (JBTM)
Enova Intl (ENVA)
Newamsterdam Pharma Company Ordinary Shares (NAMS)

View all positions for AH Lisanti Capital Growth

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Perceptive Advisors
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Artisan Partners Limited Partnership
MPM Oncology Impact Management
Caption Management

View all funds holding Palvella Therapeutics Inc Ne